Stay updated on Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Fallopian tube cancer was added to the eligible conditions in the study description. The study now targets FRα-expressing tumors across ovarian, primary peritoneal, and fallopian tube cancers.
    Difference
    0.0%
    Check dated 2026-02-18T07:25:05.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added to the site. The previous Revision: v3.4.1 entry and the outdated government operating-status notice were removed; no changes to the study content.
    Difference
    0.2%
    Check dated 2026-02-11T09:27:59.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Notice about government funding lapse and NIH operating status was added. The site revision indicator changed from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T05:50:33.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a Show glossary option, a new Last Update Submitted that Met QC Criteria timestamp, and a No FEAR Act Data notice with Revision: v3.4.0. The prior Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed.
    Difference
    0.1%
    Check dated 2026-01-28T04:15:01.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4; a minor template/version update from v3.3.3 to v3.3.4 with no user-facing changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:59:01.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Locations section updated to include new site entries across the US and international regions; earlier location groupings were removed.
    Difference
    2%
    Check dated 2025-12-23T10:13:21.000Z thumbnail image

Stay in the know with updates to Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab in Folate Receptor-Alpha Cancer Clinical Trial page.